• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2019, Vol. 21 ›› Issue (3): 305-307.DOI: 10.3969/j.issn.1671-2587.2019.03.022

Previous Articles     Next Articles

Expression and Activity Assay of High Activity Mutant V107A-R338A of FⅨ in Pichia Pastoris

DAI Yonggang   

  1. Shandong Jiaotong Hospital,Shandong,Jinan,250031
  • Received:2017-11-01 Online:2019-06-20 Published:2019-06-17

Abstract: Objective Human coagulation factor Ⅸ (hFⅨ) plays a very important role in the human endogenous coagulation. Absolute or relative lack of hFⅨ can lead to hemophilia B. In our study,Pichia pastoris was used to produce recombinanted high activity mutant hFⅨ-V107A-R338A. Methods First,PPICZaA-hFⅨ-V107A-R338A yeast expression vector was be constructed,and then transformed into Pichia pastoris SMD1168.The resistance ability recombinant strain was screened by G418,and the expression product was obtained and purified. Results The recombinant SMD1168-hFⅨ-R338A production was obtained at 80-120 mg/L in this study,which was about(44.06±2.3)% of the natural hFⅨ coagulation activity,7.75 times higher than that of the wild-type yeast recombinant hFⅨ and better than hFⅨ R338Aby 13.17).Conclusions High activity mutant hFⅨV107A -R338A producted by Pichia pastoris might be the succedaneum of natural hFⅨ

Key words: Human coagulation factor Ⅸ, high activity mutant, Pichia pastoris, Protein expression

CLC Number: